Navigation Links
Kidz-Med to Launch the Thermofocus(R) 5-in-1 Exclusively at Walgreens Stores Nationwide
Date:10/18/2007

New Device is the World's First Accurate Non-Contact Clinical Thermometer

NEW PALTZ, N.Y., Oct. 18 /PRNewswire/ -- Kidz-Med, Inc., a division of American Scientific Resources, (ASFX-OTC) today announced the U.S. launch of the Thermofocus(R) 5-in-1 thermometer, the first non-contact clinical thermometer in the world, now available in Walgreens drug stores nationwide.

The revolutionary Thermofocus 5-in-1, made in Italy and long recommended by doctors throughout Europe and Asia, takes a temperature in a second without touching a child's skin or ear. The Thermofocus 5-in-1 uses a completely safe infrared technology proven to be as accurate as a rectal thermometer.

"As a physician and father of two children, I know that no parent wants to disturb or wake a sick child to take a temperature", says Dr. Christopher F. Tirotta, founder of Kidz-Med, Inc. and Director of Cardiac Anesthesia at the Congenital Heart Institute of Miami Children's Hospital and Arnold Palmer Hospital for Children. "All you do is point the Thermofocus 5-in-1 at a child's forehead and when the LED light beam forms a single red dot, the core body temperature is displayed on an easy to read screen, and it can store up to nine temperature readings."

The Thermofocus 5-in-1, poised to become the new gold standard in thermometry, is non-invasive, quick, precise, hygienic, safe, trauma-free, and it can take 5 different types of readings: core body temperature, babies' bottle, food, bath water, and nursery. The Thermofocus 5-in-1 can even help detect inflammation, circulatory problems, and infections.

"At Walgreens, we're always seeking out new products that offer solutions to consumer needs," said Robert Tompkins, Walgreens divisional merchandise manager for Health and Wellness. "We believe the Thermofocus will have strong appeal for parents and we're pleased to be the exclusive U.S. retailer of this advanced technology."

ABOUT THE THERMOFOCUS(R) 5 in 1

-- Totall
'/>"/>

SOURCE Kidz-Med, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Glaxo launches pills to help smokers quit in 7-12 weeks
3. Action Plan Against Drug Deaths Launched
4. New Health Scheme Launched In India’s Biha
5. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
6. Dr Reddy’s Laboratories launches Hyalosy
7. Sun Pharma to launch chiral version of omeprazole soon
8. Asmanex Twisthaler launched by Schering-Plough for treatment of asthma
9. New initiative launched to fight malaria by repelling mosquitoes
10. Clarithromycin tablets to be launched in India soon
11. Guide for physicians launched to help them identify alcohol disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)..., , PEMBROKE, Bermuda, Dec. 4 /PRNew... Holdings, Ltd (NYSE: AWH ) today announced that...ficer, and Jack Sennott, Executive Vice,President ...enting at the 2009,Goldman Sachs U.S. Financial Se...Conference Center in New York City on Tuesday, Dec...
(Date:12/4/2009)..., , ANAHEIM, Calif., Dec. 4 /PRNewswire/...scent Healthcare, was selected as a finalist for t...forming Crescent,s business with the power of clou...ased on their innovative usage of Salesforce CRM o... customer success to their sales, marketing, partn...
(Date:12/4/2009)..., Working with mice, scientists at Johns Hopkins...ave shown that a protein made by a gene called "Tw...ately distinguish stem cells that drive aggressive...r cells. , Building on recent work suggesting th...in breast tumors that drives breast cancer, scient...
(Date:12/4/2009)...Outcomes same whether procedure done immediately o... Dec. 4 (HealthDay News) -- Timing of surgical rep...juries may not affect patient outcome, a new study...esult from traumatic knee dislocations that can oc...s. The optimal time to perform surgery to repair t...
(Date:12/4/2009)...Research and surveillance urged for at-risk patien...ews) -- Some childhood cancers, particularly Ewing... the risk of late recurrence, U.S. researchers hav... 12,795 five-year survivors of the most common ped...Cancer Survivor Study. , The researchers found ...
Breaking Medicine News(10 mins):Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2
... screenwriters have a lower life expectancy than n...ainly improve your health and longevity - but it d..., Texas, reveal the health risks of winning an Aca...4 years than mere nominees. This is despite having...
...rong connection between celiac disease and diabete...eliac disease in people with type 1 diabetes is ab.... Doctors have uncovered a new finding for diabeti...tion to gluten. Both CD and diabetes are common ch...
...ciation for Continence, a new study shows early in...evalence of incontinence. Incontinence is loss of ...any conditions can cause incontinence,// including... ...
...t they may one day be able to reverse some cases o...indings from an animal study that show infertile m...on to produce offspring.// According to resea...f those are a result of problems with sperm produc...
...th Care System, obese adults who undergo 'stomach ...covered 'hunger hormone' than either normal-weight... Dr. David E. Cumming from the Puget Sound Health...oblems such as type 2 diabetes and other chronic d...
... play a role in reducing the number of childhood d...who tested three different methods of zinc adminis...zinc reduced the risk of prolonged diarrhea// defi...er or the child's caregiver. More than 3 mill...
Other Medicine News:Health News:Decrease of 'Hunger Hormone' after Obesity Surgery 2
(Date:12/4/2009)...., Dec. 4 AstraZeneca (N...Drug Administration (FDA) has approved once-daily ...elease Tablets as adjunctive (add-on) treatment to...isorder (MDD). SEROQUEL XR is the only medication ...or depressive disorder as adjunctive therapy and a...
(Date:12/3/2009)...Dec. 3 A genetic variati...g a potentially life-threatening blood disorder if...emicals is one of several medical discoveries scie...ics (NYSE: DGX ) will present during the 51st Am...and Exposition, December 5-8, 2009, in New Orleans...
(Date:12/3/2009)...el., Dec. 3 ParagonRx, a Delaware-...management and optimal medication use, will host a...raft guidance on REMS - Risk Evaluation Mitigation... lifecycle management. Dr. Gary Slatko, chief med...d risk management programs, will lead the one-hour...
Breaking Medicine Technology:US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3No Increase in Brain Tumors Seen From Cell Phones 62563 1No Increase in Brain Tumors Seen From Cell Phones 62563 2No Increase in Brain Tumors Seen From Cell Phones 62563 3RN SuperUnion Founding Convention Opens Monday 62559 1RN SuperUnion Founding Convention Opens Monday 62559 2Wayne State Researchers Report a Possible Proofreading Step in DNA Synthesis by Observing Single Molecules of DNA Polymerase 62555 1Wayne State Researchers Report a Possible Proofreading Step in DNA Synthesis by Observing Single Molecules of DNA Polymerase 62555 2Wayne State Researchers Report a Possible Proofreading Step in DNA Synthesis by Observing Single Molecules of DNA Polymerase 62555 3
...the human vaccine business unit of Schering-Plough...it has reached an important milestone with the ini... program for SCH 900795, a new intranasal Live Att...al use. , , The candidate vaccine is composed of ... by the World Health Organization (WHO) for season...
...esented at USCAP Meeting , , SOUTH SAN FRANCISCO,...sdaq: RIGL ) today announced the enrollment of t...al trial of R788 (fostamatinib disodium) in patien...ymphoma (PTCL). The clinical trial,s primary obje... bio-available Syk kinase inhibitor, in patients s...
Other Medicine Technology:Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development 2Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development 3Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas 2Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas 3
...YDON is a long-pulsed Nd:YAG laser system with a w...deep-lying, superficial as well as red and blue ve...pilation in patients with darker skin types (1 to ...vement of skin texture. The handpieces special des...
...he UroVysion Bladder Cancer Kit (UroVysion Kit) is...7, 17, and loss of the 9p21 locus via fluorescence...rom persons with hematuria suspected of having bla...tended for use, in conjunction with and not in lie...
The BTA TRAK® Assay
ARION Long-Pulsed Alexandrite Laser System
Medicine Products: